NCT07309952 2025-12-30
SACTION 2501
Sun Yat-sen University
Phase 2 Not yet recruiting
Clinical Trials
10 trialsNCT06837948 2025-02-20
Neoadjuvant Chemotherapy Combined With Bispecific Antibody Versus Monoclonal Antibody in Locally Advanced NSCLC
Shanghai Pulmonary Hospital, Shanghai, China
Phase 2 Not yet recruiting
NCT06747169 2024-12-27
Efficacy and Safety of Sintilimab Combined with Nab-PP Plus Rh-endostatin in Locally Advanced/advanced and Recurrent Metastatic Squamous Non-small Cell Lung Cancer: a Single-arm, Multicenter Clinical Study
Second Affiliated Hospital of Zunyi Medical University
Phase 2 Not yet recruiting
NCT06688656 2024-11-14
Peri-E
Shanghai Chest Hospital
Phase 2 Not yet recruiting
NCT06620822 2024-10-01
Efficacy of PD-1 Inhibitor Combination Therapy in Non-small Cell Lung Cancer Patients Who Have Not Achieved Major Pathologic Response After Neoadjuvant Immunotherapy: a Multicenter, Phase II Clinical Trial
Shanghai Pulmonary Hospital, Shanghai, China
Phase 2 Not yet recruiting
NCT06604351 2024-09-19
Example
Hunan Province Tumor Hospital
Phase 2 Not yet recruiting
NCT06485557 2024-07-03
A Prospective Cohort Study of Neoadjuvant Chemotherapy Plus Sintillumab in the Treatment of Resectable NSCLC
Tang-Du Hospital
Phase 3 Not yet recruiting
NCT06221462 2024-01-25
PRIORITY
Ningbo No.2 Hospital
Phase 2 Not yet recruiting
NCT06198907 2024-01-10
JACKPOT33
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2 Not yet recruiting
NCT05306847 2022-04-01
Sintilimab Combined With Anlotinib Therapy for Initially Unresectable Non-small Cell Lung Cancer
Peking Union Medical College Hospital
Phase 2 Not yet recruiting